Trial Profile
Efficacy of Intravenous Ferric Carboxymaltose in the Improvement of Anemia in Patients With Postoperative Knee Prosthesis [Eficacia del hierro intravenoso carboximaltosa para la mejoria de la anemia postoperatoria en pacientes de protesis de rodilla]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 May 2014
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary) ; Ferrous glycine sulfate
- Indications Anaemia
- Focus Therapeutic Use
- 06 May 2014 New trial record
- 29 Apr 2014 Primary endpoint 'Haemoglobin-level' has not been met.
- 29 Apr 2014 Primary endpoint 'Disease-control-rate' has been met.